About Immuno-Oncology Insights
"I had an interest in immuno-oncology and cell therapies long before I could start working with them and during that time I was reading a lot of articles from BioInsights. It is very nice to know I might be able to contribute to the next generation`s interest in the field." Dr Pelin Candarlioglu, Senior Cell Biologist, Chair of Industry Advisory Board at EUROoCS
Immuno-Oncology Insights is a new, open access, independently peer reviewed publication specifically designed to fill a number of clear and important gaps in the current slate of journals for the industrial and academic and immuno-oncology communities.
Guided by an editorial board lead by Jon Wigginton, MD and Renier J. Brentjens, MD, PhD, Immuno-Oncology Insights places R&D challenges and progress across a wide variety of technology fields in context.
The publication collates and analyzes recent data for - and address challenges specific to - therapeutic modalities ranging from checkpoint inhibitors to cellular immunotherapies, and from oncolytic virotherapies to bispecifics.
Uniquely, Immuno-Oncology Insights provides much-needed perspective on what these data actually mean - both for each given technology area’s own prospects and future directions, and for the field as a whole.
Immuno-Oncology Insights provides a unique online content marketing and lead generation opportunity:
We can work closely with you - and your Scientific Advisory Board if you wish - to develop high quality content to demonstrate your thought-leadership:
We seek to find out as much as we can about who you are targeting, and then work to ensure the maximum number of relevant individuals are interacting with your content
We don’t sell off-the-shelf solutions. All the packages we provide are tailored to your precise marketing, educational and business development objectives.
Immuno-oncology Insights is designed for both academics and industry professionals currently struggling with the sheer weight of content and publications across the rapidly growing space.
Readership includes scientists and executives from big pharma, biotech, academia and government-funded institutions focused on checkpoint inhibitors, antibody and bispecific antibody therapeutics, oncolytic virus therapies, cancer vaccines and T cell/NK cell therapy fields:
Review our audience demographics
We offer a broad range of options, any of which can be tailored to match your current marketing and business development priorities. These include:
Sponsorship of spotlights - regular focused featured comprising peer-reviewed articles, webinars, interviews and roundtables
Participating in our webinar programme
Having one of your senior executives or scientists interviewed by our editorial team, with the resulting video, podcast and/or transcript included in an issue of the online journal
Publish an open access, peer-reviewed article, with a license to use the article on Your own website and in print at conferences
Record a FastFacts video showcasing your technology, your latest data or an application note. We will produce a one page poster summarising the key learning points and takeaways.
Work with us to convene a roundtable of KOLs to discuss a key topic area. Your roundtable will be published as both an on-demand video and a written article.
We can also act as your content marketing consultant in this sector, working closely with you (and your Scientific Advisory Board, if you wish) to develop your own topic spotlight and other value-add content such as videos, animations, surveys and infographics.
Immuno-oncology Insights provides a targeted content marketing, lead generation and promotional channel for companies providing products and services to the fast-growing sector, including:
For more information, and to discuss your needs, please contact Nicola McCall at email@example.com